Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Debt (2016)

Historic Total Debt for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q1 2016 value amounting to $4.7 million.

  • KalVista Pharmaceuticals' Total Debt rose 384.01% to $4.7 million in Q1 2016 from the same period last year, while for Mar 2016 it was $4.7 million, marking a year-over-year increase of 384.01%. This contributed to the annual value of $127000.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q1 2016, KalVista Pharmaceuticals' Total Debt is $4.7 million, which was up 384.01% from $4.6 million recorded in Q4 2015.
  • KalVista Pharmaceuticals' 5-year Total Debt high stood at $4.7 million for Q1 2016, and its period low was $4.4 million during Q4 2014.
  • Moreover, its 3-year median value for Total Debt was $4.5 million (2015), whereas its average is $4.5 million.
  • In the last 5 years, KalVista Pharmaceuticals' Total Debt soared by 392.33% in 2015 and then soared by 384.01% in 2016.
  • KalVista Pharmaceuticals' Total Debt (Quarter) stood at $4.4 million in 2014, then grew by 3.92% to $4.6 million in 2015, then rose by 0.91% to $4.7 million in 2016.
  • Its Total Debt stands at $4.7 million for Q1 2016, versus $4.6 million for Q4 2015 and $4.6 million for Q3 2015.